myriad genetics glp-1 receptor agonist weight management diabetes treatments Advances in agonists delivery systems for obesity and GLP1 Receptor Agonists—Effects beyond Obesity

The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity

requires medical knowledge to minimize risk Intranasal Intranasal delivery to target the olfactory bulb and trans-cribriform access to the brain has been explored for some peptides: Theoretical advantage: Direct CNS access, bypassing the blood-brain barrier Reality: Intranasal peptide formulations are complex and Dihexa is not commonly available in this form Evidence: No published data on intranasal Dihexa efficacy or safety Oral Bioavailability: Approximately 38% The most commonly cited bioavailability figure for oral Dihexa is approximately 38%

Important Research-Use Disclaimer: This product is supplied for laboratory and research purposes only

For evidence-based biologic treatments currently available, learn more about PRP (platelet-rich plasma) and other regenerative medicine options at the practice